Convalescent plasma is frequently administered to patients with Covid-19 and has been reported, largely on the basis of observational data, to improve clinical outcomes. Ventura A. Simonovich discusses the differences observed in clinical status between patients treated with convalescent plasma and those who received placebo.

Image courtesy of interviewee